Disease | breast cancer |
Phenotype | C0948303|peritoneal carcinoma |
Sentences | 3 |
PubMedID- 24699008 | Methods: we generated peritoneal carcinomatosis and subcutaneous xenografts of colorectal cancer ht29, breast cancer mda-mb-231, and non-small cell lung cancer a549 cell lines in nude mice. |
PubMedID- 23758908 | Moreover, the approval by the european union in 2009 of the epcam-specific antibody catumaxomab, adds a therapeutic option also in breast cancer patients with peritoneal carcinomatosis and malignant ascites [16]. |
PubMedID- 22927770 | However, in 2011, pietzner et al described a case of successful retreatment with catumaxomab for the management of malignant ascites.60 a 74-year-old female patient with breast cancer and ascites associated with peritoneal carcinomatosis was treated with catumaxomab, with resolution of her symptoms. |
Page: 1